Welcome to LookChem.com Sign In|Join Free
  • or
(R)-(+)-Carteolol is a non-selective beta blocker and alpha-1 adrenergic antagonist that is primarily used in the treatment of glaucoma and ocular hypertension. It functions by reducing the production of aqueous humor in the eye, which in turn lowers intraocular pressure. Additionally, it is believed to enhance blood flow to the optic nerve, potentially protecting against further damage in glaucoma patients. Administered as eye drops, (R)-(+)-Carteolol is generally well-tolerated with minimal systemic side effects, although it may cause local side effects such as a burning or stinging sensation.

75331-19-0

Post Buying Request

75331-19-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

75331-19-0 Usage

Uses

Used in Ophthalmology:
(R)-(+)-Carteolol is used as a therapeutic agent for the treatment of glaucoma and ocular hypertension. It helps to reduce intraocular pressure by decreasing the production of aqueous humor in the eye, which is crucial for managing these conditions. Furthermore, its potential to improve blood flow to the optic nerve may offer protective benefits against additional damage in glaucoma patients.

Check Digit Verification of cas no

The CAS Registry Mumber 75331-19-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,3,3 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 75331-19:
(7*7)+(6*5)+(5*3)+(4*3)+(3*1)+(2*1)+(1*9)=120
120 % 10 = 0
So 75331-19-0 is a valid CAS Registry Number.

75331-19-0Upstream product

75331-19-0Downstream Products

75331-19-0Relevant academic research and scientific papers

Preparation and evaluation of a triazole-bridged bis(β-cyclodextrin)–bonded chiral stationary phase for HPLC

Shuang, Yazhou,Liao, Yuqin,Wang, Hui,Wang, Yuanxing,Li, Laisheng

, p. 168 - 184 (2019/11/25)

A triazole-bridged bis(β-cyclodextrin) was synthesized via a high-yield Click Chemistry reaction between 6-azido-β-cyclodextrin and 6-propynylamino-β-cyclodextrin, and then it was bonded onto ordered silica gel SBA-15 to obtain a novel triazole-bridged bis (β-cyclodextrin)–bonded chiral stationary phase (TBCDP). The structures of the bridged cyclodextrin and TBCDP were characterized by the infrared spectroscopy, mass spectrometry, elemental analysis, and thermogravimetric analysis. The chiral performance of TBCDP was evaluated by using chiral pesticides and drugs as probes including triazoles, flavanones, dansyl amino acids and β-blockers. Some effects of the composition in mobile phase and pH value on the enantioseparations were investigated in different modes. The nine triazoles, eight flavanones, and eight dansyl amino acids were successfully resolved on TBCDP under the reversed phase with the resolutions of hexaconazole, 2′-hydroxyflavanone, and dansyl-DL-tyrosine, which were 2.49, 5.40, and 3.25 within 30 minutes, respectively. The ten β-blockers were also separated under the polar organic mode with the resolution of arotinolol reached 1.71. Some related separation mechanisms were discussed preliminary. Compared with the native cyclodextrin stationary phase (CDSP), TBCDP has higher enantioselectivity to separate more analytes, which benefited from the synergistic inclusion ability of the two adjacent cavities and bridging linker of TBCDP, thereby enabling it a promising prospect in chiral drugs and food analysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 75331-19-0